מזומנים למניה אחת Athira Pharma Corp (ATHA)

Athira Pharma, Inc. (ATHA) focuses on neuron regeneration to combat Alzheimer's, striving for scientific data precision. The development of compounds relies on AI and robotic laboratories that eliminate manual labor. Massive patient demand guarantees market absorption upon successful testing. Liquid assets per share demonstrate capital dynamics, where the value of 6.05 reflects the metric's balance between risks and resources.
פילוחים אנליטיים של חברת Athira Pharma, Inc.

Athira Pharma, Inc. (ATHA) is engaged in high-risk development of drugs to combat Alzheimer's disease. By analyzing the dynamics of the liquid position per share via GURU.Markets tools, an investor can see the specific volume of cash available per security. This indicator measures the real capital safety margin, excluding market volatility. For a biotech company, this is a critical marker of the ability to fund R&D without emergency equity issuance. The current level of reserves confirms the financial stability of Athira Pharma, Inc. (ATHA) during the period of clinical trials.